Led by gains in Divi’s Labs, Sun Pharma, Cadila Healthcare, and Dr Reddy’s Laboratories, the Nifty Pharma pack was trading marginally higher in Wednesday’s trade, with most stocks hovering near their all-time high levels.

• Bharat Electronics Secures Rs 500 Crore Orders 
• China’s Export Growth Hits Two-Year High Amid Tariff Concerns
• Trump-Led US Regime Expected to Boost India Trade in Defence and Technology
• Ashok Leyland Shares Surge 3% on Strong Q2 Earnings 
• RailTel Wins Rs 170 Crore Order from EPFO, Shares Down 2.5%

Shares of Cipla hit a new all-time high of Rs 997 in Wednesday’s session, looking poised to enter the four digit-share club after the Drugs Controller General of India (DCGI) permitted the firm to import Moderna’s Covid Vaccine with emergency use authorization in India.

Stock Covered in the news

Sun Pharma-Ltd View Detailed Analysis

Cadila Healthcare-View Detailed Analysis